Peritoneal Dialysis Market report is segmented on the basis of type, application, end-user and regional & country level. Based upon type, market is classified as peritoneal dialysis solution, device, peritoneal dialysis set, catheter and others. Based upon treatment type, market is classified as continuous ambulatory peritoneal dialysis (CAPD), automated peritoneal dialysis (APD). Based upon end-user, global market is classified as home-based dialysis, dialysis center & hospital based dialysis.
Peritoneal Dialysis Market is valued at USD 3.7 Billion in 2021 and expected to reach USD 5.9 Billion by 2028 with CAGR of 6.90% over the forecast period.
A peritoneal dialysis technique uses the patient's own body tissues inside the abdominal cavity as a filter. It is a type of dialysis which uses the peritoneum in a person's abdomen because the membrane through that fluid and dissolved substances exchanged with the blood. The PD machine then drains the fluid out of the abdomen and into a drain or waste bag and the excess wastes and fluids are removed from the body. The benefits of peritoneal dialysis provides continuous therapy, which acts more like natural kidneys, can allow for fewer dietary restrictions needle-free treatments, direct shipment of PD supplies to home or travel destination, do not have to travel to the dialysis center for treatments Greater flexibility and freedom in treatment. There is also need to be full storage space for PD supplies and a space in the home for the PD machine and supplies. Types of peritoneal dialysis are continuous ambulatory peritoneal dialysis, continuous cyclic peritoneal, intermittent peritoneal dialysis.
The regions covered in this Global Peritoneal Dialysis Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key players of the peritoneal dialysis market include -
Growing prevalence of diabetes & hypertension, technological advancements, and the shortage of organ donors & risks associated with transplants are some of the major factors driving the market growth. ESRD which is generally known as kidney failure is a significant factor increasing the demand for peritoneal dialysis. Diabetes is the most usual cause of ESRD, whereas high blood pressure is the second most common cause of ESRD. High blood pressure and diabetes are the most common chronic disease among the global population, and shortage of kidneys for transplantation due to stringent regulations regarding kidney transplantation in several countries are some of the factors which are stimulating the market growth globally. However, lack of awareness and limited demand in underdeveloped countries are some of the factors that may hinder the market growth. The rise in demand for home peritoneal dialysis treatment and increased opportunities in weak and emerging markets can create future opportunities further.
Geographically, the opportunities available in the market and in the regions of North America, Latin America, Asia Pacific, Europe and the Middle East and Africa. North America is largest market in terms of revenue owing to the growing hypertension touching to kidney failure and therefore boosting demand for peritoneal dialysis. In addition, high awareness regarding advanced automated peritoneal dialysis technique and well-established healthcare sector are some other factors supplementing the growth of the market in this region. Asia Pacific is predicted to be the fastest growing region over the forecast period.
Report Analysis | Details |
---|---|
Historical data | 2015 - 2020 |
Forecast Period | 2021 - 2028 |
Market Size in 2021: | USD 3.7 Billion |
Base year considered | 2020 |
Forecast Period CAGR %: |
6.90% |
Market Size Expected in 2028: | USD 5.9 Billion |
Tables, Charts & Figures: | 175 |
Pages | 200 |
Companies | R. Life Sciences Private Limited, Allmed Medical Corp., Braun Melsungen AG, Baxter International Inc., Cook Medical Inc., DaVita Inc., Dialife SA, Fresenius SE & Co. KGaA, Huaren , harmaceutical Co., Ltd., Medtronic Plc, Newsol Technologies Inc., Nipro Corporation, Renax Biomedical Tech Co., Ltd., Terumo Corporation, Utah Medical Products, Inc., Others. |
Segments Covered | By Product Type, By Treatment Type, By End-Users |
Regional Analysis | North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa |
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®